The topological AC effect on noncommutative phase space

The Aharonov-Casher (AC) effect in non-commutative(NC) quantum mechanics is studied. Instead of using the star product method, we use a generalization of Bopp's shift method. After solving the Dirac equations both on noncommutative space and noncommutative phase space by the new method, we obtain the corrections to AC phase on NC space and NC phase space respectively.Comment: 8 pages, Latex fil

Single-filament Composite MgB2/SUS Ribbons by Powder-In-Tube Process

We report the successful fabrication of single-filament composite MgB2/SUS ribbons, as an ultra-robust conductor type, employing the powder-in-tube (PIT) process, by swaging and cold rolling only. The remarkable transport critical current (Ic) of the non-sintered MgB2/SUS ribbon has observed, as an unexpected result. Transport critical currents Ic ~ 316 A at T = 4.2 K and Ic ~ 82 A at T = 20 K were observed at self-field, for the non-sintered composite MgB2/SUS ribbon. In addition, the persistent current density Jp values, that were estimated by Bean formula, were more than ~ 7  105 A/cm2 at T = 5 K, and ~ 1.2  105 A/cm2 at T = 30 K, for the sintered composite MgB2/SUS ribbon, at H = 0 G.Comment: 10 pages, 4 figure

Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer

Purpose: To characterize the pharmacokinetics (PK) of pertuzumab and trastuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer in the randomized, double-blind, phase III JACOB study (NCT01774786), and to evaluate the appropriateness of the pertuzumab regimen in these patients. Methods: Patients received 840 mg intravenous pertuzumab or placebo plus trastuzumab q3w and chemotherapy. Pertuzumab and trastuzumab were administered until disease progression or unacceptable toxicity. Chemotherapy was administered for up to six cycles or disease progression or unacceptable toxicity. Serum concentrations of pertuzumab and trastuzumab were measured. Pertuzumab PK was characterized across treatment cycles. The impact of anti-drug antibodies (ADAs) on pertuzumab PK and the impact of pertuzumab on trastuzumab PK were assessed. An exploratory exposure-efficacy analysis was also conducted. Results: In total, 374 patients in the pertuzumab arm had evaluable PK data. The mean observed pertuzumab steady-state serum trough (minimum) concentration (C) ± standard deviation was 114 ± 51.8 μg/mL. The target pertuzumab C of ≥ 20 μg/mL was reached in 99.3% of patients at Cycle 5 (steady state) and beyond. Greater than 90% of patients were above the PK target right after the first pertuzumab dose. There was no apparent impact of ADAs on pertuzumab PK nor of pertuzumab on trastuzumab PK. There were no differences in overall survival across Cycle 1 pertuzumab (C) or Cycle 5 pertuzumab (C) exposure quartiles. Conclusions: Pertuzumab exposure in JACOB was consistent with prior studies in advanced gastric cancer and breast cancer. The 840 mg q3w dose allowed the majority of patients in JACOB to achieve target pertuzumab concentrations and appears to be an appropriate dose selectio

Search for the Electric Dipole Moment of the tau Lepton

We have searched for a CP violation signature arising from an electric dipole moment (d_tau) of the tau lepton in the e+e- -> tau+tau- reaction. Using an optimal observable method and 29.5 fb^{-1} of data collected with the Belle detector at the KEKB collider at sqrt{s} = 10.58 GeV, we find Re(d_tau) = (1.15 +- 1.70) x 10^{-17} ecm and Im(d_tau) = (-0.83 +- 0.86) x 10^{-17} ecm and set the 95% confidence level limits -2.2 < Re(d_tau) < 4.5 (10^{-17}ecm) and -2.5 < Im(d_tau) < 0.8 (10^{-17}ecm).Comment: 15 pages, LaTeX, 21 figures, submitted to Phys. Lett.

Search for tau -> e gamma decay at Belle

We have searched for the lepton-flavor-violating decay tau -> e gamma using a data sample of 86.7/fb collected with the Belle detector at the KEKB asymmetric e^+ e^- collider. No evidence for a signal is obtained, and we set an upper limit for the branching fraction Br(tau -> e gamma) < 3.9 x 10^-7 at the 90% C.L.Comment: 11 pages, 10 figures, ReVTeX4, eps

Measurement of the gamma gamma -> pi+ pi- and gamma gamma -> K+ K- processes at energies of 2.4 - 4.1 GeV

We have measured pi+pi- and K+K- production in two-photon collisions using 87.7 /fb of data collected with the Belle detector at the asymmetric energy e+e- collider KEKB. The cross sections are measured to high precision in the two-photon center-of-mass energy (W) range between 2.4 GeV < W < 4.1 GeV and angular region |cos theta^{*}| < 0.6. The cross section ratio sigma(gammagamma->K+K-)/sigma(gammagamma->pi+pi-) is measured to be 0.89 +- 0.04(stat) +- 0.15(syst) in the range of 3.0 GeV < W < 4.1 GeV, where the ratio is energy independent. We observe a sin^{-4} theta^{*} behavior of the cross section in the same W range. Production of chi_{c0} and chi_{c2} mesons is observed in both gammagamma -> pi+pi- and gammagamma -> K+K- modes.Comment: 17 pages, 5 figures, submitted to Phys. Lett. B, errors relative to the two-photon decay width correcte

Spectra of prompt electrons from decays of B+ and B0 mesons and ratio of inclusive semielectronic branching fractions

We present spectra of prompt electrons from decays of neutral and charged B mesons. The results are based on 140 /fb of data collected by the Belle detector on the Upsilon(4S) resonance at the KEKB e+e- asymmetric collider. We tag Upsilon(4S) -> B \bar{B} events by reconstructing a B meson in one of several hadronic decay modes; the semileptonic decay of the other B meson is inferred from the presence of an identified electron. We obtain for charged and neutral B mesons the partial rates of semileptonic decay, to electrons with momentum greater than 0.6 GeV/c in the B rest frame, and their ratio b_+/b_0 = 1.08 +- 0.05 +- 0.02, where the first and second errors are statistical and systematic, respectively.Comment: 16 pages, 2 figure files, submitted to Phys. Lett.

Search for Resonant B±→K±h→K±γγB^{\pm}\to K^{\pm} h \to K^{\pm} \gamma \gamma Decays at Belle

We report measurements and searches for resonant $B^{\pm} \to K^{\pm} h \to K^{\pm} \gamma \gamma$ decays where $h$ is a $\eta,\eta^{\prime},\eta_{c},\eta_{c}(2S),\chi_{c0},\chi_{c2},J/\psi$ meson or the X(3872) particle.Comment: accepted by Physics Letters

Study of charmonia in four-meson final states produced in two-photon collisions

We report measurements of charmonia produced in two-photon collisions and decaying to four-meson final states, where the meson is either a charged pion or a charged kaon. The analysis is based on a 395fb^{-1} data sample accumulated with the Belle detector at the KEKB electron-positron collider. We observe signals for the three C-even charmonia eta_c(1S), chi_{c0}(1P) and chi_{c2}(1P) in the pi^+pi^-pi^+pi^-, K^+K^-pi^+pi^- and K^+K^-K^+K^- decay modes. No clear signals for eta_c(2S) production are found in these decay modes. We have also studied resonant structures in charmonium decays to two-body intermediate meson resonances. We report the products of the two-photon decay width and the branching fractions, Gamma_{gamma gamma}B, for each of the charmonium decay modes.Comment: 22 pages, 12 figure

Moments of the Hadronic Invariant Mass Spectrum in B --> X_c l nu Decays at Belle

We present a measurement of the hadronic invariant mass squared (M^2_X) spectrum in charmed semileptonic B meson decays B --> X_c l nu based on 140 fb^-1 of Belle data collected near the Y(4S) resonance. We determine the first, the second central and the second non-central moments of this spectrum for lepton energy thresholds ranging between 0.7 and 1.9 GeV. Full correlations between these measurements are evaluated.Comment: published version of the paper (one figure added, minor changes in the text); 16 pages, 3 figures, 10 table